OralAlpanMD

Allergy & Immunology • Springfield, VA

Associate Professor, Pediatrics, Virginia Commonwealth University, Medical College of Virginia School of Medicine

Join to view full profile

Dr. Alpan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Alpan's full profile

Already have an account?

Office
6212 Old Keene Mill Ct
Springfield, VA 22152
Phone+1 703-569-1133

Fax+1 703-569-2239

Education & Training

National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1996 - 1999
Stony Brook Medicine/University HospitalResidency, Pediatrics, 1993 - 1996
Hacettepe University FOMClass of 1990

Certifications & Licensure

MD State Medical License 1997 - 2026
VA State Medical License 2005 - 2024
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook

Clinical Trials

Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index Start of enrollment: 2011 Jan 01
Unknown status
Treatment Protocol of Replagal for Patients With Fabry Disease
No longer available
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model Start of enrollment: 2009 Jun 01
Completed
Phase 1
Exploration of Immunity in Gaucher Disease Start of enrollment: 2011 Apr 01
Completed
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases Start of enrollment: 2014 Feb 01
Completed
Phase 3
Investigation of Immune Disorders and Deficiencies Start of enrollment: 2012 Dec 01
Unknown status
Join now to see all

Publications & Presentations

PubMed

401 citations
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.
Nicola A. Hanania, Oral Alpan, Daniel L. Hamilos, John J. Condemi, Irmarie Reyes-Rivera
Annals of Internal Medicine. 2011-05-03
47 citations
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controll...
Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan
The Journal of Investigative Dermatology. 2015-01-01
109 citations
'Educated' dendritic cells act as messengers from memory to naive T helper cells.
Oral Alpan, Eric M. Bachelder, Eda Isil, Heinz Arnheiter, Polly Matzinger
Nature Immunology. 2004-05-23